Watchlist Price Alert

BioNexus Gene Lab Corp. (BGLC)

NASDAQ: BGLC · Real-Time Price · USD

2.98

0.02 (0.51%)

At close: Jun 17, 2025, 3:59 PM

3.10

4.03%

After-hours: Jun 17, 2025, 07:36 PM EDT

BioNexus Gene Lab Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	4.38M	5.93M	2.12M	2.12M	2.79M	859.08K	1.26M	839.14K	26.00
Short-Term Investments	n/a	3.31M	1.51M	1.55M	2.09M	493.04K	601K	2.55K	n/a
Long-Term Investments	1.27M	1.7M	1.15M	749.03K	281.67K	12.21K	12.08K	n/a	n/a
Other Long-Term Assets	n/a	n/a	-2.72M	n/a	-2.13M	-348.67K	n/a	n/a	n/a
Receivables	1.58M	857.26K	2.9M	3.36M	4M	15.91K	n/a	n/a	n/a
Inventory	1.39M	1.14M	977.81K	1.52M	1.18M	7.58K	15.3K	32.09K	n/a
Other Current Assets	2.88M	122.43K	n/a	147.12K	n/a	n/a	22.81K	125.94K	n/a
Total Current Assets	7.43M	8.05M	6.02M	7.15M	7.99M	882.57K	1.3M	999.72K	26.00
Property-Plant & Equipment	1.74M	1.65M	1.57M	1.68M	1.85M	336.45K	341.81K	273.16K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3M	3.35M	2.72M	2.42M	2.13M	348.67K	353.88K	273.16K	n/a
Total Assets	10.43M	11.4M	8.74M	9.57M	10.12M	1.23M	1.65M	1.27M	26.00
Account Payables	1.5M	1.4M	1.86M	2.01M	3.17M	n/a	n/a	35.09K	1.34K
Deferred Revenue	95.88K	n/a	23.12K	107.58K	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	50.82K	13.2K	16.57K	39.51K	45.75K	32.14K	n/a	n/a	n/a
Other Current Liabilities	301.28K	180.91K	86.8K	71.81K	111.44K	-32.14K	11.15K	1.04M	-1.34K
Total Current Liabilities	1.95M	1.63M	2M	2.33M	3.37M	51.57K	62.89K	1.17M	1.34K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	45.09K	n/a	n/a	n/a
Total Long-Term Liabilities	159.74K	111.02K	71.07K	65.86K	79.54K	57.3K	67.42K	4.57K	n/a
Total Liabilities	2.11M	1.74M	2.08M	2.39M	3.45M	108.87K	130.31K	1.18M	1.34K
Total Debt	210.56K	133.4K	56.77K	76.95K	123.42K	89.44K	82.06K	n/a	n/a
Common Stock	17.33M	17.19M	10.93M	10.78M	10.78M	6.48M	6.65M	5.21M	n/a
Retained Earnings	-3.44M	-1.84M	1.16M	1.51M	760.79K	-333.31K	-86.84K	-113.3K	-1.44K
Comprehensive Income	-555K	-677.29K	-409.06K	-100.26K	133.68K	-17.1K	-26.98K	14.05K	126.00
Shareholders Equity	8.32M	9.66M	6.67M	7.18M	6.66M	1.12M	1.52M	94.63K	-1.31K
Total Investments	1.27M	1.7M	1.15M	749.03K	281.67K	12.21K	12.08K	2.55K	n/a